Literature DB >> 7077783

A familial aggregation of pancreatic cancer. An in vitro study.

B S Danes, H T Lynch.   

Abstract

The incidence of pancreatic cancer has been increasing steadily in the United States and other industrialized nations. Its obscure etiology and difficult early diagnosis tend to hobble effective control programs. Innovative methods, such as biomarkers, might provide clues to its inevitable occurrence in high-risk individuals. We studied a family in which four individuals manifested pancreatic cancer verified through two generations. Cell cultures from split-thickness skin biopsy specimens were obtained for 24 members from three generations (17 bloodline relatives, seven family members by marriage) as well as ten nonfamily normal subjects, none with a family history of solid tumors. One of the constant features of human monolayer dermal cultures has been diploidy. Hyperdiploidy, other than tetraploidy, has been rarely observed in cultures from normal subjects without a family history of solid tumors. We observed increased in vitro hyperdiploidy in eight of 17 family members studied.

Entities:  

Mesh:

Year:  1982        PMID: 7077783

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  9 in total

1.  Inherited predisposition to pancreatic cancer.

Authors:  E Efthimiou; T Crnogorac-Jurcevic; N R Lemoine; T A Brentnall
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

2.  Relationship of family cancer history to the expression of p53, p21WAF-1, HER-2/neu, and K-ras mutation in pancreatic adenocarcinoma.

Authors:  S T Dergham; M C Dugan; P Arlauskas; W Du; V K Vaitkevicius; J D Crissman; F H Sarkar
Journal:  Int J Pancreatol       Date:  1997-06

3.  Familial pancreatic adenocarcinoma and HLA-typing.

Authors:  D O'Mahony; M J Whelton
Journal:  Postgrad Med J       Date:  1989-04       Impact factor: 2.401

Review 4.  Pancreatic adenocarcinoma: epidemiology and genetics.

Authors:  T Y Flanders; W D Foulkes
Journal:  J Med Genet       Date:  1996-11       Impact factor: 6.318

Review 5.  Identifying people at a high risk of developing pancreatic cancer.

Authors:  Alison P Klein
Journal:  Nat Rev Cancer       Date:  2012-12-06       Impact factor: 60.716

6.  Familial pancreatic adenocarcinoma: association with diabetes and early molecular diagnosis.

Authors:  J P Evans; W Burke; R Chen; R L Bennett; R A Schmidt; E P Dellinger; M Kimmey; D Crispin; T A Brentnall; D R Byrd
Journal:  J Med Genet       Date:  1995-05       Impact factor: 6.318

7.  Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma.

Authors:  J A DiGiuseppe; R H Hruban; G J Offerhaus; M J Clement; F M van den Berg; J L Cameron; A D van Mansfeld
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

8.  Cancer of the pancreas in two brothers and one sister.

Authors:  P Ghadirian; A Simard; J Baillargeon
Journal:  Int J Pancreatol       Date:  1987 Oct-Dec

9.  Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study.

Authors:  H T Lynch; G J Voorhees; S J Lanspa; P S McGreevy; J F Lynch
Journal:  Br J Cancer       Date:  1985-08       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.